Assessment of the Verus Frame in Tibial Intramedullary Nailing

Starting soon · Not applicable

Conditions studied: Tibial Fracture

In brief

This prospective, single-arm Post-Market Clinical Follow-Up (PMCF) study, utilizing a registry-based control group, will assess the Verus frame's effectiveness in achieving precise tibial rotation and alignment during intramedullary nailing procedure, as well as safety of the device. The results will be compared to AO-approved criteria to ensure comprehensive evaluation of its new benefits, regulatory compliance, and continued clinical use. Tibial intramedullary nailing is the gold standard for tibial fracture fixation, where accurate alignment and rotation are crucial for optimal recovery and long-term outcomes.

Key facts

Study ID

NCT07362121

Run by

Hemitec Finland Oy

People needed

25

Starts

2026-05-01

Expected to finish

2027-05-01

Last updated by the study team

2026-01-23

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Tibial fracture to be operated by suprapatellar intramedullary nailing technique
• 18-80 years old
• Signed informed consent

You may not qualify if…

• Situations where intramedullary fixation is otherwise contraindicated, e.g., active or potential infection, osteoporosis or where a patient's cooperation cannot be guaranteed.
• Pregnancy, breastfeeding
• Open fractures with severe soft tissue damage
• Polytrauma
• Previous tibia fracture

Where it is running

• Turku University Hospital — Turku, Finland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.